Dr. Kashmira Date is a physician-epidemiologist and global vaccines executive with over 20 years of leadership across Pfizer, Johnson & Johnson, the U.S. Centers for Disease Control and Prevention (CDC), and global public health. Her expertise spans vaccine development, global medical and scientific strategy, epidemiology, evidence generation, vaccine policy and introduction, pandemic preparedness, and health equity. At Pfizer, she has led global medical strategy for respiratory vaccine and antiviral pipeline assets, including RSV combination products. Previously, she led medical and scientific strategy for COVID-19 and Ebola vaccines at Johnson & Johnson.
During more than a decade at CDC, she established and led vaccine portfolios for typhoid, cholera, and other new vaccines, working closely with ministries of health, WHO, UNICEF, Gavi, and international partners to advance vaccine policy, evidence generation, and introduction. She also chaired the Global Task Force on Cholera Control's Oral Cholera Vaccine Working Group and led international epidemiology activities during CDC's COVID-19 response.
An alumna of CDC's Epidemic Intelligence Service, Dr. Date is an Adjunct Associate Professor at Emory University's Rollins School of Public Health and a recipient of the prestigious Presidential Early Career Award for Scientists and Engineers (PECASE), awarded by the Obama Administration in 2017.